KTN's online platform helps you to make the connections you need

 

The Knowledge Transfer Network (KTN) has refreshed its online platform to intelligently connect you to relevant events, funding, thought pieces and specialist staff to help your business innovate and grow.

You can discover content using your area of interest, from Defence Security to transport; from space to health – all major UK economic sectors are covered. Once you have selected your interests, using our intelligent tagging system, we will then display rich and relevant content related to your area, often from surprising sources.

An example might be new satellite technology from the space sector that is applicable in the agri-food sector. KTN-UK.co.uk will help you form these unusual and valuable connections.

All content on the platform has been carefully curated by our team of innovation specialists – not by an automated algorithm – so you can be confident that KTN is connecting you to the most relevant cutting-edge information.

 

The move also marks a closer alignment with our main funder, Innovate UK , with the website branding making a clear visual link. Knowledge Transfer Network is Innovate UK's innovation network partner, and also works with other funders to provide innovation networking services and fulfil our mission to drive UK growth.

We link new ideas and opportunities with expertise, markets and finance through our network of businesses, universities, funders and investors. From agri-food to autonomous systems and from energy to design, KTN combines expertise in all sectors with the ability to cross boundaries. Connecting with KTN can lead to potential partners, horizon-expanding events and innovation insights relevant to your needs.

Visit our people pages to connect directly with expertise in your sector.

Visit the KTN refreshed online platfom here

« go back

Pharmaceutical regulators meet for urgent talks on dementia

Pharmaceutical regulators from 10 countries have met for urgent talks on ways of using existing laws and regulations to support dementia research and development.

The meeting in Geneva on 10 November, led by the British government, brought together the Medicines and Healthcare products Regulatory Agency (MHRA) and regulators from the European Union, the United States, Canada, Japan, Switzerland, the World Health Organization (WHO) and the Organisation for Economic Co-operation and Development (OECD) .

Currently, pharmaceutical companies have to spend millions, and sometimes years, tailoring drug development efforts to meet the regulatory requirements of individual countries.Jeremy Hunt, Secretary of State for Health in England, said:“Dementia is a global challenge, so I am delighted that the Medicines and Healthcare products Regulatory Agency will be part of the Geneva meeting which aims to speed up drug development efforts, encourage investment in new treatments and ultimately help to find a cure.”

Today is the first of 3 meetings worldwide. The next steps will be to identify areas of focus for future collaboration and coordination that could make a difference to millions of people in the UK and abroad. The ultimate aim of the meetings is to bring about innovative, higher quality therapies that could prevent, cure and improve the quality of life for people with dementia.

Rona Ambrose, Canada’s Minister of Health said:

Our government is committed to taking action to address the growing problem of dementia. By working in cooperation with international partners we’re accelerating efforts to harness the best research and find innovative ways in treatment and prevention that will benefit all those affected by dementia.”